Short bowel syndrome

This study follows 250 people in Japan with short bowel syndrome who are receiving teduglutide (Revestive) injections. Researchers will monitor side effects and how well the drug controls symptoms over 36 months. The goal is to see if teduglutide can safely reduce the need for in…

This study tests the long-term safety and effectiveness of a weekly injection called glepaglutide in adults with short bowel syndrome, a condition where the body cannot absorb nutrients properly. Participants who completed a previous trial will receive the drug for about 2 years.…

This study looks at the long-term safety and effectiveness of a drug called glepaglutide in adults with short bowel syndrome (SBS), a condition where the body can't absorb enough nutrients from food. Participants who were already in earlier trials can continue treatment for up to…

This phase 3 trial tests the long-term safety of glepaglutide, a drug that mimics a natural gut hormone, in 145 adults with short bowel syndrome. The goal is to see if it can safely help the gut absorb more nutrients, potentially reducing the need for intravenous feeding. Partici…

This study looks at a device called RELiZORB that attaches to a feeding tube to pre-digest fat, making it easier for children with short bowel syndrome to absorb nutrients. The goal is to see if using it daily for 90 days can safely reduce or eliminate the need for intravenous (I…

This study tests a program called FACE-Rare, designed to support family caregivers of children with rare, life-limiting diseases. The program includes three sessions to help families prepare for future medical decisions and improve their quality of life. Researchers will compare …

This study is a registry that will review medical records of 1,000 patients treated for benign or malignant gastrointestinal diseases between 2005 and 2030. Researchers will look at survival, symptoms like heartburn and swallowing trouble, and quality of life. The goal is to lear…

Short bowel syndrome is a rare condition where the bowel is too short to absorb enough nutrients. This study gives green bean puree to 60 adults with and without the condition to see if they can tolerate fiber. Researchers will track symptoms, weight, and changes in gut bacteria …

This registry follows about 1,800 people with short bowel syndrome (SBS) to see how safe and effective the drug teduglutide is over the long term in everyday medical practice. It includes both patients who take teduglutide and those who do not. The main goal is to monitor for col…